Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4877187
Max Phase: Preclinical
Molecular Formula: C23H19F4N3O2
Molecular Weight: 445.42
Molecule Type: Unknown
Associated Items:
ID: ALA4877187
Max Phase: Preclinical
Molecular Formula: C23H19F4N3O2
Molecular Weight: 445.42
Molecule Type: Unknown
Associated Items:
Canonical SMILES: O=C(NCCO)c1c(F)ccc2c1CCN2c1cc(Cc2cc(F)c(F)c(F)c2)ccn1
Standard InChI: InChI=1S/C23H19F4N3O2/c24-16-1-2-19-15(21(16)23(32)29-6-8-31)4-7-30(19)20-12-13(3-5-28-20)9-14-10-17(25)22(27)18(26)11-14/h1-3,5,10-12,31H,4,6-9H2,(H,29,32)
Standard InChI Key: SFZRGRCCXQGZPB-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 445.42 | Molecular Weight (Monoisotopic): 445.1413 | AlogP: 3.65 | #Rotatable Bonds: 6 |
Polar Surface Area: 65.46 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 13.47 | CX Basic pKa: 5.62 | CX LogP: 4.10 | CX LogD: 4.09 |
Aromatic Rings: 3 | Heavy Atoms: 32 | QED Weighted: 0.45 | Np Likeness Score: -1.07 |
1. (2020) 1-heteroaryl-indoline-4-carboxamides as modulators of gpr52 useful for the treatment or prevention of disorders related thereto, |
Source(1):